Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Acute Lung Injury
Maple Syrup Urine Disease
Acute Respiratory Distress Syndrome
MSUD
Epidermolysis Bullosa
Urea Cycle Disorders
Rare Diseases
Chronic Lung Disease
Metabolic Disorders
ARDS
Acute Lung Disease
Clinical Trials
Phenylketonuria
UCD
Lung Fibrosis
Pulmonary Sarcoidosis
PKU
Genetic Medicine
Rare Disease
EB
Date founded
2013
Funding rounds raised
Total raised
$2.8M
from 1 investors over 1 rounds
R
RELIEF THERAPEUTICS Holding AG raised $2.8M on May 24, 2016
Investors: GEM Management Limited